These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31660979)

  • 1. Effects of VEGF blockade on the dynamics of the inflammatory landscape in glioblastoma-bearing mice.
    Soubéran A; Brustlein S; Gouarné C; Chasson L; Tchoghandjian A; Malissen M; Rougon G
    J Neuroinflammation; 2019 Oct; 16(1):191. PubMed ID: 31660979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic dynamics of microglial and monocyte-derived cells in glioblastoma-bearing mice.
    Ricard C; Tchoghandjian A; Luche H; Grenot P; Figarella-Branger D; Rougon G; Malissen M; Debarbieux F
    Sci Rep; 2016 May; 6():26381. PubMed ID: 27193333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma.
    Scholz A; Harter PN; Cremer S; Yalcin BH; Gurnik S; Yamaji M; Di Tacchio M; Sommer K; Baumgarten P; Bähr O; Steinbach JP; Trojan J; Glas M; Herrlinger U; Krex D; Meinhardt M; Weyerbrock A; Timmer M; Goldbrunner R; Deckert M; Braun C; Schittenhelm J; Frueh JT; Ullrich E; Mittelbronn M; Plate KH; Reiss Y
    EMBO Mol Med; 2016 Jan; 8(1):39-57. PubMed ID: 26666269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Combination Therapy with MET and VEGF Inhibitors for MET-overexpressing Glioblastoma.
    Okuda T; Tasaki T; Nakata S; Yamashita K; Yoshioka H; Izumoto S; Kato A; Fujita M
    Anticancer Res; 2017 Jul; 37(7):3871-3876. PubMed ID: 28668888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF as a modulator of the innate immune response in glioblastoma.
    Turkowski K; Brandenburg S; Mueller A; Kremenetskaia I; Bungert AD; Blank A; Felsenstein M; Vajkoczy P
    Glia; 2018 Jan; 66(1):161-174. PubMed ID: 28948650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy.
    Guo J; Shinriki S; Su Y; Nakamura T; Hayashi M; Tsuda Y; Murakami Y; Tasaki M; Hide T; Takezaki T; Kuratsu J; Yamashita S; Ueda M; Li JD; Ando Y; Jono H
    Oncotarget; 2014 Aug; 5(15):6353-64. PubMed ID: 25071012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI.
    Deng L; Stafford JH; Liu SC; Chernikova SB; Merchant M; Recht L; Martin Brown J
    Neoplasia; 2017 Jan; 19(1):1-7. PubMed ID: 27940247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF.
    Di Tacchio M; Macas J; Weissenberger J; Sommer K; Bähr O; Steinbach JP; Senft C; Seifert V; Glas M; Herrlinger U; Krex D; Meinhardt M; Weyerbrock A; Timmer M; Goldbrunner R; Deckert M; Scheel AH; Büttner R; Grauer OM; Schittenhelm J; Tabatabai G; Harter PN; Günther S; Devraj K; Plate KH; Reiss Y
    Cancer Immunol Res; 2019 Dec; 7(12):1910-1927. PubMed ID: 31597643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of innate immune cell subsets across spatial and temporal scales in an EAE mouse model.
    Caravagna C; Jaouën A; Desplat-Jégo S; Fenrich KK; Bergot E; Luche H; Grenot P; Rougon G; Malissen M; Debarbieux F
    Sci Rep; 2018 Mar; 8(1):5146. PubMed ID: 29572472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspective: targeting VEGF-A and YKL-40 in glioblastoma - matter matters.
    Holst CB; Pedersen H; Obara EAA; Vitting-Seerup K; Jensen KE; Skjøth-Rasmussen J; Lund EL; Poulsen HS; Johansen JS; Hamerlik P
    Cell Cycle; 2021 Apr; 20(7):702-715. PubMed ID: 33779510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment.
    Hardcastle J; Mills L; Malo CS; Jin F; Kurokawa C; Geekiyanage H; Schroeder M; Sarkaria J; Johnson AJ; Galanis E
    Neuro Oncol; 2017 Apr; 19(4):493-502. PubMed ID: 27663389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling tumor invasion: bevacizumab and BMP4 for glioblastoma.
    Rahman M; Azari H; Deleyrolle L; Millette S; Zeng H; Reynolds BA
    Future Oncol; 2013 Sep; 9(9):1389-96. PubMed ID: 23980685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival.
    Kloepper J; Riedemann L; Amoozgar Z; Seano G; Susek K; Yu V; Dalvie N; Amelung RL; Datta M; Song JW; Askoxylakis V; Taylor JW; Lu-Emerson C; Batista A; Kirkpatrick ND; Jung K; Snuderl M; Muzikansky A; Stubenrauch KG; Krieter O; Wakimoto H; Xu L; Munn LL; Duda DG; Fukumura D; Batchelor TT; Jain RK
    Proc Natl Acad Sci U S A; 2016 Apr; 113(16):4476-81. PubMed ID: 27044098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
    Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
    Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
    Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
    World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.
    Piao Y; Park SY; Henry V; Smith BD; Tiao N; Flynn DL; de Groot JF
    Neuro Oncol; 2016 Sep; 18(9):1230-41. PubMed ID: 26965451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric Mouse model to track the migration of bone marrow derived cells in glioblastoma following anti-angiogenic treatments.
    Achyut BR; Shankar A; Iskander AS; Ara R; Knight RA; Scicli AG; Arbab AS
    Cancer Biol Ther; 2016; 17(3):280-90. PubMed ID: 26797476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropilin-1 modulates TGFβ signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy.
    Kwiatkowski SC; Guerrero PA; Hirota S; Chen Z; Morales JE; Aghi M; McCarty JH
    PLoS One; 2017; 12(9):e0185065. PubMed ID: 28938007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.
    Yabo YA; Moreno-Sanchez PM; Pires-Afonso Y; Kaoma T; Nosirov B; Scafidi A; Ermini L; Lipsa A; Oudin A; Kyriakis D; Grzyb K; Poovathingal SK; Poli A; Muller A; Toth R; Klink B; Berchem G; Berthold C; Hertel F; Mittelbronn M; Heiland DH; Skupin A; Nazarov PV; Niclou SP; Michelucci A; Golebiewska A
    Genome Med; 2024 Apr; 16(1):51. PubMed ID: 38566128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of Glutamate Transport Enhances Treg Function That Promotes VEGF Blockade Resistance in Glioblastoma.
    Long Y; Tao H; Karachi A; Grippin AJ; Jin L; Chang YE; Zhang W; Dyson KA; Hou AY; Na M; Deleyrolle LP; Sayour EJ; Rahman M; Mitchell DA; Lin Z; Huang J
    Cancer Res; 2020 Feb; 80(3):499-509. PubMed ID: 31723000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.